Avadel Pharmaceuticals Plc Stock Volatility

AVDL Stock  USD 17.38  0.61  3.39%   
Avadel Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Avadel Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0842, which signifies that the company had a 0.0842% return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for Avadel Pharmaceuticals PLC, which you can use to evaluate the volatility of the firm. Please makes use of Avadel Pharmaceuticals' mean deviation of 2.47, and Risk Adjusted Performance of 0.0592 to double-check if our risk estimates are consistent with your expectations. Key indicators related to Avadel Pharmaceuticals' volatility include:
30 Days Market Risk
Chance Of Distress
30 Days Economic Sensitivity
Avadel Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Avadel daily returns, and it is calculated using variance and standard deviation. We also use Avadel's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Avadel Pharmaceuticals volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Avadel Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Avadel Pharmaceuticals at lower prices. For example, an investor can purchase Avadel stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Avadel Pharmaceuticals' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Avadel Stock

  0.66A Agilent Technologies Financial Report 28th of May 2024 PairCorr
  0.81YS YS Biopharma Report 22nd of April 2024 PairCorr

Moving against Avadel Stock

  0.88DMTK DermTech Financial Report 2nd of May 2024 PairCorr
  0.79DRUG Bright Minds BiosciencesPairCorr
  0.78KA Kineta Inc Financial Report 9th of May 2024 PairCorr
  0.78ME 23Andme HoldingPairCorr
  0.72VCYT Veracyte Financial Report 2nd of May 2024 PairCorr
  0.7DRMA Dermata Therapeutics Financial Report 9th of May 2024 PairCorr
  0.6VCNX VaccinexPairCorr
  0.55DRTS Alpha Tau Medical Financial Report 28th of May 2024 PairCorr
  0.53CDIOW Cardio DiagnosticsPairCorr

Avadel Pharmaceuticals Market Sensitivity And Downside Risk

Avadel Pharmaceuticals' beta coefficient measures the volatility of Avadel stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Avadel stock's returns against your selected market. In other words, Avadel Pharmaceuticals's beta of 1.22 provides an investor with an approximation of how much risk Avadel Pharmaceuticals stock can potentially add to one of your existing portfolios. Avadel Pharmaceuticals PLC currently demonstrates below-average downside deviation. It has Information Ratio of 0.06 and Jensen Alpha of 0.22. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Avadel Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Avadel Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Avadel Pharmaceuticals Demand Trend
Check current 90 days Avadel Pharmaceuticals correlation with market (NYSE Composite)

Avadel Beta

    
  1.22  
Avadel standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  3.65  
It is essential to understand the difference between upside risk (as represented by Avadel Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Avadel Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in avadel stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Avadel Pharmaceuticals.

Using Avadel Put Option to Manage Risk

Put options written on Avadel Pharmaceuticals grant holders of the option the right to sell a specified amount of Avadel Pharmaceuticals at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Avadel Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Avadel Pharmaceuticals' position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Avadel Pharmaceuticals will be realized, the loss incurred will be offset by the profits made with the option trade.

Avadel Pharmaceuticals' PUT expiring on 2024-04-19

   Profit   
       Avadel Pharmaceuticals Price At Expiration  

Current Avadel Pharmaceuticals Insurance Chain

DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Put
2024-04-19 PUT at $17.5-0.53020.36321502024-04-190.3 - 0.650.5View
View All Avadel Pharmaceuticals Options

Avadel Pharmaceuticals Stock Volatility Analysis

Volatility refers to the frequency at which Avadel Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Avadel Pharmaceuticals' price changes. Investors will then calculate the volatility of Avadel Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Avadel Pharmaceuticals' volatility:

Historical Volatility

This type of stock volatility measures Avadel Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Avadel Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Avadel Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Avadel Pharmaceuticals' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Avadel Pharmaceuticals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Avadel Pharmaceuticals Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 1.2211 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Avadel Pharmaceuticals will likely underperform.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Avadel Pharmaceuticals or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Avadel Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Avadel stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Avadel Pharmaceuticals PLC has an alpha of 0.2154, implying that it can generate a 0.22 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Avadel Pharmaceuticals' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how avadel stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Avadel Pharmaceuticals Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Avadel Pharmaceuticals Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of Avadel Pharmaceuticals is 1187.02. The daily returns are distributed with a variance of 13.33 and standard deviation of 3.65. The mean deviation of Avadel Pharmaceuticals PLC is currently at 2.48. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 0.62
α
Alpha over NYSE Composite
0.22
β
Beta against NYSE Composite1.22
σ
Overall volatility
3.65
Ir
Information ratio 0.06

Avadel Pharmaceuticals Stock Return Volatility

Avadel Pharmaceuticals historical daily return volatility represents how much of Avadel Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 3.6511% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 0.6214% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Avadel Pharmaceuticals Volatility

Volatility is a rate at which the price of Avadel Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Avadel Pharmaceuticals may increase or decrease. In other words, similar to Avadel's beta indicator, it measures the risk of Avadel Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Avadel Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for Next Year
Selling And Marketing Expenses2.3 K1.6 K
Market Cap445.9 M468.2 M
Avadel Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Avadel Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Avadel Pharmaceuticals' price varies over time.

3 ways to utilize Avadel Pharmaceuticals' volatility to invest better

Higher Avadel Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Avadel Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Avadel Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Avadel Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Avadel Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Avadel Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Avadel Pharmaceuticals Investment Opportunity

Avadel Pharmaceuticals PLC has a volatility of 3.65 and is 5.89 times more volatile than NYSE Composite. Compared to the overall equity markets, volatility of historical daily returns of Avadel Pharmaceuticals PLC is lower than 32 percent of all global equities and portfolios over the last 90 days. You can use Avadel Pharmaceuticals PLC to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Avadel Pharmaceuticals to be traded at $16.68 in 90 days.

Modest diversification

The correlation between Avadel Pharmaceuticals PLC and NYA is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and NYA in the same portfolio, assuming nothing else is changed.

Avadel Pharmaceuticals Additional Risk Indicators

The analysis of Avadel Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Avadel Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Avadel Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Avadel Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Avadel Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Avadel Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Avadel Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Avadel Pharmaceuticals PLC.
When determining whether Avadel Pharmaceuticals is a strong investment it is important to analyze Avadel Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avadel Pharmaceuticals' future performance. For an informed investment choice regarding Avadel Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Avadel Pharmaceuticals information on this page should be used as a complementary analysis to other Avadel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Avadel Stock analysis

When running Avadel Pharmaceuticals' price analysis, check to measure Avadel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avadel Pharmaceuticals is operating at the current time. Most of Avadel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Avadel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avadel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Avadel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Avadel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.00)
Revenue Per Share
0.349
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.58)
Return On Equity
(4.81)
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.